Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Cancer Research
|
November 10, 2017
Complement Activation via a C3a Receptor Pathway Alters CD4<sup>+</sup> T Lymphocytes and Mediates Lung Cancer Progression
Jeff W Kwak, Jennifer Laskowski, Howard Y Li, et al.
NPJ Precision Oncology
|
February 5, 2023
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, et al.
Journal for Immunotherapy of Cancer
|
April 22, 2021
Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis
Michael W Knitz, Thomas E Bickett, Laurel B Darragh, et al.
Cancer Research
|
March 27, 2024
NPEPPS Is a Druggable Driver of Platinum Resistance
Robert T Jones, Mathijs Scholtes, Andrew Goodspeed, et al.
Science Advances
|
February 26, 2019
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy
Megan M Tu, Francis Y F Lee, Robert T Jones, et al.
Nature Cancer
|
November 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Science Translational Medicine
|
September 22, 2017
Neutrophil transfer of <i>miR-223</i> to lung epithelial cells dampens acute lung injury in mice
Viola Neudecker, Kelley S Brodsky, Eric T Clambey, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Cancer Research
|
November 10, 2017
Complement Activation via a C3a Receptor Pathway Alters CD4<sup>+</sup> T Lymphocytes and Mediates Lung Cancer Progression
Jeff W Kwak, Jennifer Laskowski, Howard Y Li, et al.
NPJ Precision Oncology
|
February 5, 2023
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, et al.
Journal for Immunotherapy of Cancer
|
April 22, 2021
Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis
Michael W Knitz, Thomas E Bickett, Laurel B Darragh, et al.
Cancer Research
|
March 27, 2024
NPEPPS Is a Druggable Driver of Platinum Resistance
Robert T Jones, Mathijs Scholtes, Andrew Goodspeed, et al.
Science Advances
|
February 26, 2019
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy
Megan M Tu, Francis Y F Lee, Robert T Jones, et al.
Nature Cancer
|
November 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Science Translational Medicine
|
September 22, 2017
Neutrophil transfer of <i>miR-223</i> to lung epithelial cells dampens acute lung injury in mice
Viola Neudecker, Kelley S Brodsky, Eric T Clambey, et al.
Page
of 6